Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression
Phase of Trial: Phase IV
Latest Information Update: 15 May 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 18 May 2010 Actual patient number amended from 366 to 370 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual number of patients (366) added as reported by ClinicalTrials.gov record.